Berkshire's Split-Screen Story: A Defensive Favorite That Still Writes Tech Checks
Published on 10/31/2026 at 04:02 | Editorial boerse-global.de
Berkshire Hathaway shares have become a haven for investors rattled by artificial-intelligence valuations — yet the conglomerate's own checkbook tells a more nuanced story.
Over the past 30 days, the stock has climbed 11%, a move media reports on October 25 linked to mounting unease over AI-related equities. An earlier round of coverage, on October 20, had already tied a record closing price for the Class B shares to a rotation away from AI names. Both accounts describe investor demand, not a company-confirmed catalyst — a distinction that matters more than it first appears.
Buying Berkshire as an alternative to AI stocks is one thing. Assuming Berkshire itself shuns technology is another entirely. The two claims sit on separate planes, and the company's recent capital moves blur any simple read-across.
A $330 Million Counterweight
Roughly two weeks ago, Berkshire added another $330 million to its stake in Bending Spoons, lifting its holding in the Italian software group to 4%. The position was built from scratch: Berkshire put $600 million into the company at its July IPO, according to Bending Spoons.
Should investors sell immediately? Or is it worth buying Berkshire Hathaway?
The latest leg came as a private placement, with the company issuing 10 million ordinary shares at $33.00 apiece — freshly minted stock rather than a block bought from existing holders. That is new capital flowing into a technology business, not a retreat from the sector.
Nor is the portfolio moving in a single direction. Berkshire sold DaVita shares back to the dialysis provider under their repurchase agreement and remains a shareholder; this was a trim, not an exit. The contrasting trades make it hard to read a uniform buy or sell signal across the equity book.
Insurance Build-Out Runs on Its Own Track
Personnel and expansion news form a separate layer of the story. On Tuesday, Berkshire Hathaway Specialty Insurance announced the promotion of Virginie Pelletier to head its Executive & Professional Liability practice in France. About two weeks ago, the same unit unveiled its entry into Poland, naming Carsten Keune as country manager. One is a leadership appointment, the other a new-market launch — both concern the European insurance organization, not the investment portfolio.
Meanwhile, Berkshire Hathaway Travel Protection published its annual ranking of the safest destinations for 2027 on Wednesday, with Canada, New Zealand and Australia taking the top spots. That release belongs to the travel-insurance business and stands apart from the hiring and expansion moves.
Berkshire Hathaway at a turning point? This analysis reveals what investors need to know now.
Two Price Targets, One Message
Analyst sentiment has been supportive. UBS raised its target on the Class A shares from $906,011 to $942,405 on October 22, keeping a buy rating, according to media reports. The bank also lifted its Class B target to $628 from $604, maintaining its recommendation there as well.
Those calls assess the stock as a whole. A promotion in France, a Polish debut and a pair of offsetting stake changes each describe something narrower — specific shifts inside a sprawling group. Weighing the news flow by its economic substance, rather than by headline count, is the more useful exercise. On that measure, Berkshire is simultaneously a defensive pick for nervous investors and an active buyer of technology — and neither fact cancels the other.
Ad
Berkshire Hathaway Stock: New Analysis - 31 October
Fresh Berkshire Hathaway information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
